BBOT

1.8102.69%
PJ

Pedro J. Beltran

Chief Executive Officer and Director

Dr. Pedro J. Beltran, M.D., Ph.D., is Chief Executive Officer of BridgeBio Oncology Therapeutics, Inc. from April 20, 2026. and as a member of our board of directors since April 2026. He is Chief Scientific Officer of TheRas, Inc. from July 2023. He is Senior Vice President and Head of Biology for Oncology Therapeutics at BridgeBio Pharma, Inc. He served as Senior Vice President of Oncology at BridgeBio Pharma, Inc. since March 2022. He served as Senior Vice President of Biology at Unity Biotechnology, Inc. from December 2017 to July 2020. Prior to that, Dr. Beltran held roles of increasing responsibility at Amgen from September 2003 to November 2017, including as Executive Director of Discovery Research. At the University of Miami, Dr. Beltran served as Assistant Scientist from November 2001 to August 2003 and was a postdoctoral fellow work in Molecular and Cellular Pharmacology d postdoctoral at the University of Miami, from November 1998 to November 2001. He received a B.S. in Molecular Biology from the Florida Institute of Technology and a Ph.D. in Cancer Biology from the University of Texas, Health Science Center at Houston.

Positions